Corbus Pharmaceuticals Holdings, Inc.
Hedge Funds Holdings
Last updated:
Corbus Pharmaceuticals Holdings, Inc.‘s stocks are currently a part of 58 hedge funds’ portfolios, which represents 43.05% of the total amount of its stocks outstanding. This makes up a total of 31.80M shares of Corbus Pharmaceuticals Holdings, Inc.. Compared to the previous quarter, the number fell by -15.04% or -5.63M shares fewer. As for the holding position changes, 22.41% (13) of current hedge fund investors increased the number of shares held, 25.86% (15) of current holders sold a part of the shares held, and 25.86% (15) closed the holdings completely. 11 hedge funds are new holders of Corbus Pharmaceuticals Holdings, Inc. stock in Q2 2022, it is 18.97% of total holders.
Hedge funds holding Corbus Pharmaceuticals Holdings (Q3 2017 – Q2 2022)
| Q3 2017 | 67 |
|---|---|
| Q4 2017 | 87 |
| Q1 2018 | 77 |
| Q2 2018 | 80 |
| Q3 2018 | 76 |
| Q4 2018 | 78 |
| Q1 2019 | 98 |
| Q2 2019 | 100 |
| Q3 2019 | 97 |
| Q4 2019 | 100 |
| Q1 2020 | 106 |
| Q2 2020 | 138 |
| Q3 2020 | 114 |
| Q4 2020 | 102 |
| Q1 2021 | 105 |
| Q2 2021 | 93 |
| Q3 2021 | 81 |
| Q4 2021 | 71 |
| Q1 2022 | 62 |
| Q2 2022 | 58 |
Hedge funds changes in Corbus Pharmaceuticals Holdings positions (Q3 2017 – Q2 2022)
| Q3 2017 | 10 | 28 | 16 | 10 | 3 |
|---|---|---|---|---|---|
| Q4 2017 | 26 | 33 | 16 | 6 | 6 |
| Q1 2018 | 9 | 36 | 16 | 16 | 0 |
| Q2 2018 | 17 | 29 | 18 | 14 | 2 |
| Q3 2018 | 12 | 25 | 23 | 16 | 0 |
| Q4 2018 | 9 | 32 | 22 | 6 | 9 |
| Q1 2019 | 27 | 41 | 14 | 7 | 9 |
| Q2 2019 | 19 | 30 | 28 | 13 | 10 |
| Q3 2019 | 14 | 24 | 32 | 18 | 9 |
| Q4 2019 | 19 | 33 | 25 | 14 | 9 |
| Q1 2020 | 26 | 43 | 17 | 17 | 3 |
| Q2 2020 | 44 | 45 | 25 | 11 | 13 |
| Q3 2020 | 12 | 50 | 31 | 36 | -15 |
| Q4 2020 | 21 | 21 | 41 | 33 | -14 |
| Q1 2021 | 20 | 38 | 22 | 16 | 9 |
| Q2 2021 | 16 | 22 | 32 | 29 | -6 |
| Q3 2021 | 10 | 22 | 27 | 22 | 0 |
| Q4 2021 | 12 | 23 | 18 | 23 | -5 |
| Q1 2022 | 7 | 15 | 22 | 17 | 1 |
| Q2 2022 | 11 | 13 | 15 | 15 | 4 |
Hedge funds changes in Corbus Pharmaceuticals Holdings stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 1,578,000 | 2,373,000 |
|---|---|---|
| Q4 2017 | 263,000 | 1,397,000 |
| Q1 2018 | 418,000 | 1,713,000 |
| Q2 2018 | 510,000 | 825,000 |
| Q3 2018 | 13,000,003,629,000 | 16,000,002,841,000 |
| Q4 2018 | 1,061,000 | 3,151,000 |
| Q1 2019 | 3,321,000 | 5,077,000 |
| Q2 2019 | 2,385,000 | 4,027,000 |
| Q3 2019 | 1,191,000 | 2,126,000 |
| Q4 2019 | 587,000 | 1,545,000 |
| Q1 2020 | 6,889,000 | 2,052,000 |
| Q2 2020 | 49,162,000 | 24,792,000 |
| Q3 2020 | 11,700,000 | 11,103,000 |
| Q4 2020 | 1,385,000 | 776,000 |
| Q1 2021 | 2,558,000 | 2,376,000 |
| Q2 2021 | 4,907,000 | 1,487,000 |
| Q3 2021 | 763,000 | 862,000 |
| Q4 2021 | 290,000 | 332,000 |
| Q1 2022 | 240,000 | 151,000 |
| Q2 2022 | 118,000 | 58,000 |